cyclopentane has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, IM; Li, J; Littlejohn, R; Liu, J; Ma, W; Stansfield, BK; Su, H; Weintraub, NL; Zhou, J; Zou, J | 1 |
| Hao, Y; Kang, S; Li, D; Liu, A; Liu, Y; Sun, D; Sun, H; Xu, C; Yan, C; Zhou, C | 1 |
2 other study(ies) available for cyclopentane and Cardiac Failure
| Article | Year |
|---|---|
Transient inhibition of neddylation at neonatal stage evokes reversible cardiomyopathy and predisposes the heart to isoproterenol-induced heart failure.
Topics: Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Cyclopentanes; Disease Models, Animal; Heart Failure; Hypertrophy, Left Ventricular; Isoproterenol; Myocytes, Cardiac; NEDD8 Protein; Pyrimidines; Rats, Sprague-Dawley; Ubiquitin-Conjugating Enzymes; Ubiquitination; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Chronic activation of the G protein-coupled receptor 30 with agonist G-1 attenuates heart failure.
Topics: Animals; Cyclopentanes; Estrogens; Female; Heart Failure; Isoproterenol; Natriuretic Peptide, Brain; Ovariectomy; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled | 2012 |